Sponsor content
6 result(s) found, displaying 1 to 6
-
Australian public assessment report (AusPar)Nemluvio (nemolizumab) has been approved to treat moderate-to-severe atopic dermatitisin combination with topical corticosteroids and/ or topical calcineurin inhibitors in adults and patients aged 12 years and above who weigh at least 30 kg and who are candidates for systemic therapy. Nemluvio has also been approved for the treatment of adults with moderate-to-severe prurigo nodularis who are candidates for systemic therapy.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Trifarotene
-
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Brimonidine (as tartrate)
-
Australian public assessment report (AusPar)Australian Public Assessment Report Clobetasol propionate
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Doxycycline monohydrate